Načítá se...
Liver-targeted antiviral peptide nanocomplexes as potential anti-HCV therapeutics
Great success in HCV therapy was achieved by the development of direct-acting antivirals (DAA). However, the unsolved issues such as high cost and genotype dependency drive us to pursue additional therapeutic agents to be used instead or in combination with DAA. The cationic peptide p41 is one of su...
Uloženo v:
| Vydáno v: | Biomaterials |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4562313/ https://ncbi.nlm.nih.gov/pubmed/26298393 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.biomaterials.2015.08.014 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|